Skip to main content
BGI Genomics Co., Ltd. logo

BGI Genomics Co., Ltd. — Investor Relations & Filings

Ticker · 300676 ISIN · CNE100003449 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 1,656 across all filing types
Latest filing 2021-05-28 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300676

About BGI Genomics Co., Ltd.

https://www.bgi.com

BGI Genomics Co., Ltd. is a leading provider of integrated solutions for precision medicine, specializing in genomic sequencing and proteomic services. The company offers a comprehensive portfolio of clinical diagnostics and research services across various fields, including reproductive health, oncology, and infectious diseases. Key products include non-invasive prenatal testing, hereditary cancer screening, and pathogen identification tools. Leveraging proprietary DNBseq sequencing technology, BGI Genomics provides high-throughput, cost-effective genomic data analysis to healthcare providers, research institutions, and pharmaceutical companies worldwide. The organization focuses on advancing personalized medicine through large-scale genomic research and the development of innovative diagnostic applications, aiming to improve health outcomes by making advanced genetic insights accessible to a global population.

Recent filings

Filing Released Lang Actions
独立董事候选人声明（曹亚）
Board/Management Information Classification · 95% confidence The document is a formal declaration by an independent director candidate of Shenzhen BGI Genomics Co., Ltd. It contains detailed statements about the candidate's qualifications, compliance with relevant laws and regulations, and independence criteria. There are no financial statements, earnings data, or management discussion of financial results. The content is focused on governance and compliance related to board membership qualifications. This type of document is typically related to board or management information, specifically announcements or declarations concerning board members or candidates. Therefore, the most appropriate classification is 'Board/Management Information' (MANG). The document length is about 4,836 characters, which is consistent with a detailed declaration rather than a brief announcement or a full report.
2021-05-28 Chinese
第二届监事会第三十次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 30th meeting of the second Supervisory Board of Shenzhen BGI Genomics Co., Ltd. It details the election of new non-employee representative supervisors, their resumes, and the approval of supervisor allowances. The document includes voting results and references to compliance with company law and regulations. It does not contain financial statements or detailed financial performance data, nor is it a transcript or presentation. It is an official announcement related to board/supervisory management changes and governance matters. Therefore, it fits best under Board/Management Information (MANG). The document length is short and it is not a report publication announcement or certification. Hence, the classification is MANG with high confidence.
2021-05-28 Chinese
独立董事提名人声明（吴育辉）
Board/Management Information Classification · 100% confidence The document is a public statement from the board of Shenzhen BGI Genomics Co., Ltd. nominating an individual (Wu Yuhui) as an independent director candidate for the company's third board of directors. It includes detailed declarations about the nominee's qualifications, compliance with relevant laws, regulations, and stock exchange rules, and confirms no conflicts of interest or disqualifications. There is no financial data, no report of financial results, no voting results, no management changes, no legal proceedings, or other types of filings. This document is clearly related to board/management information, specifically the nomination of a board member. Therefore, the appropriate classification is Board/Management Information (MANG). The document length is sufficient and contains substantive content about the nomination, not just an announcement or a brief notice.
2021-05-28 Chinese
独立董事候选人声明（杜兰）
Board/Management Information Classification · 95% confidence The document is a detailed declaration by an independent director candidate of Shenzhen BGI Genomics Co., Ltd. It contains statements about the candidate's qualifications, compliance with various regulatory requirements, and independence criteria. The content is focused on the candidate's eligibility and compliance with laws and regulations related to independent directors. There is no financial data, no report of financial performance, no voting results, no management changes, and no announcement of a report publication. The document is a formal declaration related to board/management information, specifically concerning the appointment or candidacy of an independent director. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length (5077 characters) supports that this is a full declaration rather than a brief announcement or certification.
2021-05-28 Chinese
关于公司监事会换届选举的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the election and changes in the company's supervisory board (监事会换届选举). It details the nomination and election process of new supervisors, the end of term for a current supervisor, and related compliance with company law and regulations. There is no financial data, audit information, or report publication mentioned. The content focuses on board/management changes specifically related to the supervisory board members. Therefore, the document fits the category of Board/Management Information (MANG). The document length is short and it is not a report or a report announcement, so it is not RPA or RNS.
2021-05-28 Chinese
关于召开2021年第二次临时股东大会的通知
AGM Information Classification · 95% confidence The document is a detailed notice about convening the 2021 second extraordinary general meeting (临时股东大会) of Shenzhen BGI Genomics Co., Ltd. It includes information on meeting date, voting procedures, agenda items related to board and supervisory committee elections, proxy forms, and voting instructions. There is no financial data or results reported, nor is it a transcript or presentation. It is not an announcement of voting results but a notice to shareholders about the meeting and how to participate and vote. This fits the definition of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting or similar shareholder meetings. The document length and content confirm it is the meeting notice itself, not a brief announcement or a report publication announcement. Therefore, the classification is AGM-R with high confidence.
2021-05-28 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.